We found that down-regulation of FZD7 impaired cell proliferation in CML cell line by increasing G0/G1 phase and decreasing S phase cells, and restored the sensitivity of CML cells to IM. The gene discussed is FZD7; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.